Source: Eur Respir J 2014; 43: 963-965
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Souza Rogerio, Fernandes Caio J.C., Hoeper Marius M.. Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension. Eur Respir J 2014; 43: 963-965

Member's Comments

No comment yet.

Related content which might interest you: Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 More on idiopathic pulmonary arterial hypertension with a low diffusing capacity Source: Eur Respir J, 50 (2) 1700354; 10.1183/13993003.00354-2017 Year: 2017 Influence of ventilation inhomogeneity on diffusing capacity of carbon monoxide in smokers without COPD Source: ERJ Open Res, 7 (1) 00706-2020; 10.1183/23120541.00706-2020 Year: 2021 Diffusing capacity of the lung for carbon monoxide (DLCO) and pulmonary blood flow during incremental and intermittent-work exercise tests Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange Year: 2008 Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021 Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients Source: Eur Respir J 2012; 39: 119-124 Year: 2012 Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients Source: Eur Respir J 2011; 39: 119-124 Year: 2012 Standardisation of the single-breath determination of carbon monoxide uptake in the lung Source: Eur Respir J 2005; 26: 720-735 Year: 2005 Diffusing capacity for carbon monoxide (DLco) may predict appearance of pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Change in diffusing capacity for carbon monoxide as a predictor of outcomes in connective tissue disease-associated pulmonary arterial hypertension: Analysis from the REVEAL registry Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021 Pulmonary veno-occlusive disease Source: Eur Respir J 2009; 33: 189-200 Year: 2009 Ventilatory inefficiency relative to oxygen uptake and carbon dioxide output are independent predictors of mortality in pulmonary arterial hypertension Source: Annual Congress 2013 –Respiratory physiology in health and disease Year: 2013 Does carbon monoxide diffusing capacity (DLCO) effect results of pulmonary rehabilitation? Source: International Congress 2015 – Latest insights into pulmonary rehabilitation Year: 2015 Adjusting diffusing capacity of the lung for carbon monoxide for haemoglobin level Source: Eur Respir J 2013; 41: 489 Year: 2013 Carbon monoxide diffusing capacity (DLCO) usefulness in patients suffering from exertional dyspnea with or without oxygen desaturation during exercise testing Source: Eur Respir J 2002; 20: Suppl. 38, 491s Year: 2002 Exposition to CO among humans due to the measurement of the diffusing capacity by carbon monoxide Source: Annual Congress 2007 - Acute and chronic effects of air pollution Year: 2007 Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis Source: Eur Respir J, 50 (4) 1701008; 10.1183/13993003.01008-2017 Year: 2017